Yahoo Web Search

  1. NASDAQ: BLUE) Corvus Pharmaceuticals Inc (NASDAQ: CRVS) DelMar Pharmaceuticals Inc (NASDAQ: DMP) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) Erytech Pharma ...

  2. The following is a roundup of top developments in the biotech space over the last 24 hours. Biotech stocks that hit 52-week highs Sept. AstraZeneca plc (NYSE: AZN) GlaxoSmithKline plc (NYSE: ...

  3. NASDAQ: GILD) Type of Application: sNDA Candidate: Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) Indication: Pre-exposure prophylaxis, or PrEP, for HIV-1 infection Date ...

  4. Coherus Biosciences Inc (NASDAQ: CHRS) The Medicines Company (NASDAQ: MDCO) (Biotech stocks that hit 52-week lows Sept.

  5. Theravance's (TBPH) newly-launched COPD drug Yupelri is witnessing a solid adoption while its pipeline programs are also progressing well. However, excessive reliance on Yupelri for revenues is a woe.

  6. The Medicines Company (NASDAQ: MDCO) Ra Pharmaceuticals Inc (NASDAQ: RARX) (announced a deal to be bought by Belgium's UCB) (Biotech stocks that hit 52-week lows Oct. 10.

  7. NASDAQ: AMGN)'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: CLVLY)'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory ...

  8. J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug

    Bloomberg via Yahoo FinanceOct 09 11:27 AM

    A state court jury in Philadelphia Tuesday concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the punishment award in the first Pennsylvania case in which ...

  1. Ads
    related to Janssen Pharmaceuticals Inc